Clinical ResearchCoronaryLong-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial
Coronary
Under an Elsevier user license
open archive
Key Words
balloon angioplasty
drug-eluting stent restenosis
paclitaxel-eluting balloon
paclitaxel-eluting stent
Abbreviations and Acronyms
BA
balloon angioplasty
CI
confidence interval
DES
drug-eluting stent(s)
HR
hazard ratio
MI
myocardial infarction
PEB
paclitaxel-eluting balloon
PES
paclitaxel-eluting stent(s)
TLR
target lesion revascularization
Cited by (0)
Dr. Kastrati has been issued or has applied for patents related to stent technology. Dr. Byrne has received lecture fees from B. Braun Melsungen and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Kufner and Cassese contributed equally to this work.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.